FDA Proposes Rule to End 'Self-Affirmed' Food Safety, Mandating Notification for All New Ingredients
The FDA has proposed a sweeping rule that would require food manufacturers to notify the agency before introducing new ingredients, aiming to close a decades-old loophole in the nation's food safety system.
In 1958, the United States Congress created a practical and seemingly straightforward exemption for common, historically consumed food ingredients like vinegar, salt, and baking soda. Lawmakers declared these everyday staples to be 'Generally Recognized as Safe' (GRAS), meaning they could bypass the formal, rigorous premarket approval process required for entirely new food additives.
However, nearly seven decades later, that narrow exemption has steadily evolved into a broad regulatory pathway. Today, it is routinely used by food manufacturers to introduce thousands of novel chemicals, synthetic preservatives, and complex emulsifiers into the American food supply—often without ever notifying the federal government or submitting their safety data for independent review.[4][5]
That long-standing era of voluntary disclosure and industry self-policing is now facing a major structural overhaul. On August 10, 2026, the U.S. Food and Drug Administration (FDA) officially proposed a sweeping new rule that would require food manufacturers to formally notify the agency before bringing any new self-affirmed GRAS ingredient to the consumer market.
The proposal aims to close what consumer advocates, public health officials, and nutrition researchers have long criticized as a 'secret loophole' in the nation's food safety system—one that has allowed an unknown number of unvetted substances to end up on grocery store shelves.[3][5][7]
'Shifting to a mandatory notification system closes a decades-old information gap, giving the FDA the comprehensive visibility needed to enhance postmarket safety,' Acting FDA Commissioner Kyle Diamantas told reporters during the policy's announcement.
The regulatory move serves as a central pillar of the Trump administration's broader Make America Healthy Again (MAHA) agenda, spearheaded by Health and Human Services Secretary Robert F. Kennedy Jr. The initiative seeks to tighten federal oversight of ultra-processed foods, modernize nutrition science, and restore public trust by demanding greater transparency regarding the synthetic additives that make up a significant portion of the modern American diet.[4][7]
To fully grasp the significance of the FDA's proposed rule, it helps to look closely at how the current food safety system operates in practice. Under existing federal regulations, a food company can independently determine that a new chemical additive is safe for human consumption.
They do this by convening their own panel of qualified experts to review publicly available scientific evidence. Once this internal panel reaches a consensus, the company can legally introduce the ingredient into interstate commerce without any statutory obligation to inform the FDA, submit their safety data, or wait for a government green light.[3][5][6]
While the FDA does operate a voluntary GRAS notification program for companies that wish to seek official acknowledgment, participation remains entirely optional. Because so many manufacturers choose to bypass this voluntary step to protect trade secrets or speed up product launches, the agency estimates that at least 1,000 substances are currently used in human food based on independent safety conclusions that were never submitted for federal review.
These unreviewed substances include certain chemical preservatives found in popular breakfast cereals, specialized emulsifiers used in ice creams and salad dressings, and select low-calorie sweeteners featured in sugar-free desserts.[3][8]
The newly proposed rule would fundamentally alter this dynamic by mandating baseline transparency across the entire food and beverage industry. Any person, corporation, or supplier introducing a substance into the food supply under the GRAS provision would be legally required to submit a formal notice to the FDA.
This mandatory submission must detail the scientific basis and evidence for their safety conclusion. Crucially, this requirement covers both direct food ingredients and indirect substances, such as chemicals, dyes, and coatings that might migrate into food from its packaging during manufacturing or storage.[3][6]
Once a mandatory GRAS notice is submitted by a manufacturer, the FDA would initiate a structured review timeline. The agency would first have a 45-day initial evaluation period to determine whether the submission is complete and officially file it.
Following that filing, regulators would have 180 days to conduct a thorough safety check of the provided data. During this window, the FDA retains the option to request additional scientific information, raise specific safety concerns, or ask the company to voluntarily delay the ingredient's commercial rollout if regulators identify potential risks to public health.[6][7]
However, there is a crucial and widely debated limitation to the new regulatory framework: it does not establish a strict premarket approval system. Because of the specific statutory constraints written into the Federal Food, Drug, and Cosmetic Act, companies retain the legal right to independently conclude that a substance is GRAS. Consequently, they can still begin marketing and selling the ingredient before submitting a notice, or while the FDA is actively evaluating their mandatory submission. The rule changes the reporting requirements, but it does not act as a hard gatekeeper.[3][4][6]
Establishing a true premarket review system—where a novel ingredient cannot legally be sold or consumed until the FDA explicitly reviews and approves its safety data—would require a literal act of Congress to rewrite the 1958 law. 'What we're doing is requiring companies that utilize the pathway to notify us of their conclusions so that we have greater visibility,' Diamantas clarified to the press, noting that the agency is aggressively working within the boundaries of its current legal authority to maximize oversight without overstepping its statutory mandate.[7]
For everyday consumers, this means the immediate contents of grocery store shelves and pantry staples will not change overnight. The primary shift is in federal data collection, transparency, and post-market oversight. By forcing food companies to finally show their scientific work, the FDA will be vastly better positioned to identify inadequately supported safety conclusions. This comprehensive visibility will allow regulators to prioritize their enforcement resources and take swift, targeted action against specific substances that pose a genuine, verifiable risk to public health.[3][7]
The FDA has pointed to several high-profile past instances where the lack of mandatory notification created significant regulatory blind spots. Cases involving caffeinated alcoholic beverages, Delta-8 THC products, and certain highly concentrated botanical extracts forced the agency to scramble to address safety concerns regarding GRAS substances that were already widely marketed and consumed. A mandatory notification system is explicitly designed to provide earlier intervention opportunities, allowing regulators to catch these problematic formulations before they become deeply embedded in the national food supply.[3]
Beyond policing new ingredients, the proposed rule also directly addresses the thousands of self-affirmed GRAS substances that are already actively embedded in the American food supply. Rather than forcing food manufacturers to undergo a full, highly burdensome retroactive review for every single legacy ingredient—a process that could paralyze both the industry and the agency's review staff—the FDA is proposing a streamlined, time-limited submission pathway to get these existing chemicals officially on the federal books.[2][4][6]
For a period of exactly one year after the final rule takes effect, manufacturers will be able to submit basic, abbreviated information about their existing GRAS ingredients. This required data includes the substance's intended uses, the specific use levels in various foods, and concrete evidence that the ingredient is already circulating in interstate commerce.
The FDA estimates this streamlined administrative process will take companies roughly 31 hours to complete per ingredient, a significant reduction compared to the estimated 180 hours required to prepare and submit a full GRAS notice for a brand-new additive.[2][3][6]
To further enhance transparency, the FDA plans to publish and maintain a comprehensive public inventory of all submitted GRAS notifications. This database will significantly expand consumer, academic, and stakeholder visibility into exactly what is entering the food supply. However, public health experts and former FDA officials caution that inclusion on this public list does not equate to a formal FDA endorsement of safety. The registry simply serves as a transparent acknowledgment that the agency has received the company's safety rationale and is aware of the ingredient's presence in the market.[3][7][8]
The proposal is currently open for a standard 120-day public comment period, which will run through December 9, 2026, allowing industry groups, scientists, and citizens to weigh in on the framework. If the rule is finalized as currently written, it would officially take effect 60 days after its final publication. From there, food manufacturers would be granted an 18-month grace period to adjust their internal compliance programs and meet the new mandatory notification requirements for all future ingredient innovations.[3][6]
While consumer advocacy groups have largely welcomed the FDA's proposal as a long-overdue and necessary step toward transparency, some prominent voices argue it simply does not go far enough. Organizations like the Environmental Working Group continue to push for strong, science-based safety standards that require independent FDA review and explicit approval before any new chemical is allowed in food. They argue that as long as companies can sell products while the FDA reviews their paperwork, the fundamental risks of the GRAS loophole remain intact.[7]
For everyday shoppers trying to navigate the grocery aisles, the practical takeaway is reassuring but nuanced. The American food supply is not inherently dangerous today, but the regulatory blind spots that allowed novel, ultra-processed additives to bypass federal scrutiny are finally being illuminated. Over the next few years, this increased government visibility and public transparency is expected to naturally drive food manufacturers toward more rigorous internal safety testing, cleaner ingredient profiles, and a more cautious approach to food innovation.[7]
Key points
- The FDA has proposed a rule requiring food manufacturers to notify the agency when they self-affirm an ingredient as 'Generally Recognized as Safe' (GRAS).
- Currently, companies can independently determine an additive is safe and use it in food without ever informing federal regulators.
- The rule aims to close a decades-old loophole that has allowed thousands of unvetted chemicals into the U.S. food supply.
- The mandate does not establish a premarket approval system; companies can still market ingredients while the FDA reviews their notices.
What we don’t know
- It remains unclear how the FDA will handle the massive influx of data once thousands of legacy GRAS ingredients are submitted for review.
- We do not yet know if Congress will take further action to grant the FDA explicit authority to mandate premarket approvals for all new food chemicals.
- It is uncertain how many existing self-affirmed GRAS ingredients might be flagged for safety concerns once their data is finally disclosed to regulators.
How we got here
1958
Congress passes the Food Additives Amendment, creating the GRAS exemption for common ingredients like salt and vinegar.
1997
The FDA introduces a voluntary notification program, allowing companies to self-affirm GRAS status without mandatory federal review.
March 2025
The Department of Health and Human Services orders the FDA to explore formal rulemaking to close the GRAS loophole.
August 10, 2026
The FDA officially proposes a rule mandating that companies notify the agency of all self-affirmed GRAS ingredients.
December 9, 2026
The public comment period for the proposed mandatory notification rule closes.
- Public Health Advocates
- Argue that the GRAS loophole has allowed potentially unsafe chemicals into the food supply and demand stricter premarket reviews.
- Food Industry Counsel
- Emphasize that self-affirmed GRAS ingredients are backed by expert consensus and warn that mandatory notifications could slow down food innovation.
- Federal Regulators
- Focus on increasing transparency and post-market oversight within the boundaries of their current statutory authority.
Perspectives this story doesn't cover
- Small-scale food tech startups, who may struggle with the administrative costs of the new mandatory notification process.
- International food safety regulators, whose stricter premarket approval frameworks often contrast with the U.S. GRAS system.
Sources
[1]Alston & BirdFood Industry CounselFood & Beverage Advisory | FDA Proposes Rule to Eliminate Self-Affirmed GRAS Pathway
Read on Alston & Bird →
[2]Green QueenPublic Health AdvocatesFDA Proposes Rule to End Self-Affirmed GRAS
Read on Green Queen →
[3]Food Safety MagazineFederal RegulatorsFDA Proposes Mandatory GRAS Notifications for Ingredients Introduced to U.S. Food Supply
Read on Food Safety Magazine →
[4]Packaging DiveFood Industry CounselFDA proposes rule to close 'loophole' on food ingredients
Read on Packaging Dive →
[5]Los Angeles TimesPublic Health AdvocatesFDA proposes rule to close 'secret GRAS loophole'
Read on Los Angeles Times →
[6]Akin GumpFood Industry CounselFDA Proposes Rule to Eliminate Self-Affirmed GRAS Pathway
Read on Akin Gump →
[7]AP NewsPublic Health AdvocatesFDA proposes requiring food companies to notify regulators before adding new ingredients to foods
Read on AP News →
[8]AJMCFederal RegulatorsFDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition
Read on AJMC →
More in Health
See all →Infectious Diseases
WHO Reports Global Cholera Deaths Surged 30% to Highest Level Since 1999
5 sources
Childhood Obesity
Novo Nordisk and UNICEF Expand $18 Million Initiative to Prevent Childhood Obesity in Seven Countries
5 sources
Gene Therapy
Beacon's Gene Therapy Laru-zova Restores Dim-Light Vision in Pivotal Trial for Rare Blinding Disease
7 sources
Alcohol Metabolism
How Alcohol Dehydrogenase and Aldehyde Dehydrogenase Metabolize Ethanol to Acetate, and Why Genetic Variants Cause Flushing
8 sources
Comments
Every angle. Every day.
Get Health stories with full source coverage and perspective breakdowns, free every day.



